Frontiers in Oncology (Jan 2023)
Prediction of portal dosimetry quality assurance results using log files-derived errors and machine learning techniques
Abstract
ObjectiveThis work aims to use machine learning models to predict gamma passing rate of portal dosimetry quality assurance with log file derived features. This allows daily treatment monitoring for patients and reduce wear and tear on EPID detectors to save cost and prevent downtime.Methods578 VMAT trajectory log files selected from prostate, lung and spine SBRT were used in this work. Four machine learning models were explored to identify the best performing regression model for predicting gamma passing rate within each sub-site and the entire unstratified data. Predictors used in these models comprised of hand-crafted log file-derived features as well as modulation complexity score. Cross validation was used to evaluate the model performance in terms of R2 and RMSE.ResultUsing gamma passing rate of 1%/1mm criteria and entire dataset, LASSO regression has a R2 of 0.121 ± 0.005 and RMSE of 4.794 ± 0.013%, SVM regression has a R2 of 0.605 ± 0.036 and RMSE of 3.210 ± 0.145%, Random Forest regression has a R2 of 0.940 ± 0.019 and RMSE of 1.233 ± 0.197%. XGBoost regression has the best performance with a R2 and RMSE value of 0.981 ± 0.015 and 0.652 ± 0.276%, respectively.ConclusionLog file-derived features can predict gamma passing rate of portal dosimetry with an average error of less than 2% using the 1%/1mm criteria. This model can potentially be applied to predict the patient specific QA results for every treatment fraction.
Keywords
